Objectives With the present study, we aimed to investigate the association between menopausal hormone therapy (HT) and risk of colorectal cancer (CRC). Setting Cohort study based on the linkage of Norwegian population-based registries. Participants We selected 466822 Norwegian women, aged 55-79, alive and residing in Norway as of 1 January 2004, and we followed them from 2004 to 2008. Each woman contributed person-years at risk as non-user, current user and/or past HT user. Outcome measures The outcome of interest was adenocarcinoma of the colorectal tract, overall, by anatomic site and stage at diagnosis. Incidence rate ratios (RRs) with 95% CIs were estimated by Poisson regression and were used to evaluate the association between HT and CRC incidence. Results During the median follow-up of 4.8 years, 138 655 (30%) women received HT and 3799 (0.8%) incident CRCs occurred. Current, but not past, use of HT was associated with a lower risk of CRC (RR 0.88; 95% CI 0.80 to 0.98). RRs for localised, regionally advanced and metastatic CRC were 1.13 (95% CI 0.91 to 1.41), 0.81 (95% CI 0.70 to 0.94) and 0.79 (95% CI 0.62 to 1.00), respectively. RRs for current use of oestrogen therapy (ET) were 0.91 (95% CI 0.80 to 1.04) while RR for current use of combined oestrogen-progestin therapy (EPT) was 0.85 (95% CI 0.70 to 1.03), as compared with no use of HT. The same figures for ET and EPT in oral formulations were 0.83 (95% CI 0.68 to 1.03) and 0.86 (95% CI 0.71 to 1.05), respectively. Conclusions In our nationwide cohort study, HT use lowered the risk of CRC, specifically the most advanced CRC.
Botteri, E., Støer, N., Sakshaug, S., Graff-Iversen, S., Vangen, S., Hofvind, S., et al. (2017). Menopausal hormone therapy and colorectal cancer: A linkage between nationwide registries in Norway. BMJ OPEN, 7(11) [10.1136/bmjopen-2017-017639].
|Citazione:||Botteri, E., Støer, N., Sakshaug, S., Graff-Iversen, S., Vangen, S., Hofvind, S., et al. (2017). Menopausal hormone therapy and colorectal cancer: A linkage between nationwide registries in Norway. BMJ OPEN, 7(11) [10.1136/bmjopen-2017-017639].|
|Tipo:||Articolo in rivista - Articolo scientifico|
|Carattere della pubblicazione:||Scientifica|
|Presenza di un coautore afferente ad Istituzioni straniere:||Si|
|Titolo:||Menopausal hormone therapy and colorectal cancer: A linkage between nationwide registries in Norway|
|Autori:||Botteri, E; Støer, N; Sakshaug, S; Graff-Iversen, S; Vangen, S; Hofvind, S; de Lange, T; Bagnardi, V; Ursin, G; Weiderpass, E|
|Data di pubblicazione:||2017|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1136/bmjopen-2017-017639|
|Appare nelle tipologie:||01 - Articolo su rivista|